Connection

Perry Halushka to Humans

This is a "connection" page, showing publications Perry Halushka has written about Humans.
Connection Strength

0.457
  1. Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers. Annu Rev Pathol. 2019 01 24; 14:211-238.
    View in: PubMed
    Score: 0.024
  2. Scientific retreats with 'speed dating': networking to stimulate new interdisciplinary translational research collaborations and team science. J Investig Med. 2017 02; 65(2):382-390.
    View in: PubMed
    Score: 0.021
  3. Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoring. Prostaglandins Other Lipid Mediat. 2011 Nov; 96(1-4):41-4.
    View in: PubMed
    Score: 0.015
  4. Is the training of biomedical scientists at a crossroads? Acad Med. 2009 Apr; 84(4):421-3.
    View in: PubMed
    Score: 0.012
  5. Toward individualized analgesic therapy: functional cyclooxygenase 1 and 2 haplotypes. Clin Pharmacol Ther. 2006 May; 79(5):404-6.
    View in: PubMed
    Score: 0.010
  6. Castration reduces platelet thromboxane A2 receptor density and aggregability. QJM. 2005 May; 98(5):349-56.
    View in: PubMed
    Score: 0.009
  7. A controlled trial of amlodipine for cocaine dependence: a negative report. J Subst Abuse Treat. 2005 Mar; 28(2):197-204.
    View in: PubMed
    Score: 0.009
  8. Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther. 2003 Jan; 73(1):122-30.
    View in: PubMed
    Score: 0.008
  9. Amlodipine reduces blood pressure and headache frequency in cocaine-dependent outpatients. J Psychoactive Drugs. 2002 Oct-Dec; 34(4):415-9.
    View in: PubMed
    Score: 0.008
  10. Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease. Mol Ther. 2022 04 06; 30(4):1451-1464.
    View in: PubMed
    Score: 0.008
  11. Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol. 2001 Feb; 51(2):143-6.
    View in: PubMed
    Score: 0.007
  12. Circulating miRNA 887 is differentially expressed in ARDS and modulates endothelial function. Am J Physiol Lung Cell Mol Physiol. 2020 06 01; 318(6):L1261-L1269.
    View in: PubMed
    Score: 0.007
  13. Thromboxane A(2) receptors: where have you gone? Prostaglandins Other Lipid Mediat. 2000 Mar; 60(4-6):175-89.
    View in: PubMed
    Score: 0.007
  14. Exosomes from Endothelial Progenitor Cells Improve the Outcome of a Murine Model of Sepsis. Mol Ther. 2018 05 02; 26(5):1375-1384.
    View in: PubMed
    Score: 0.006
  15. Modification on ligand binding to TXA2/PGH2 receptors by diethylpyrocarbonate. Adv Exp Med Biol. 1997; 400A:235-40.
    View in: PubMed
    Score: 0.005
  16. Inhibition of testosterone 5 alpha-reductase: evidence for tissue-specific regulation of thromboxane A2 receptors. J Pharmacol Exp Ther. 1996 Dec; 279(3):1386-91.
    View in: PubMed
    Score: 0.005
  17. The role of miRNAs in cardiovascular disease risk factors. Atherosclerosis. 2016 11; 254:271-281.
    View in: PubMed
    Score: 0.005
  18. Characterization of the cloned HEL cell thromboxane A2 receptor: evidence that the affinity state can be altered by G alpha 13 and G alpha q. J Pharmacol Exp Ther. 1996 May; 277(2):1132-9.
    View in: PubMed
    Score: 0.005
  19. Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells. Life Sci. 1996; 58(8):683-90.
    View in: PubMed
    Score: 0.005
  20. Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational study. Crit Care. 2015 Dec 18; 19:440.
    View in: PubMed
    Score: 0.005
  21. Thromboxane A2 receptors. J Lipid Mediat Cell Signal. 1995 Oct; 12(2-3):361-78.
    View in: PubMed
    Score: 0.005
  22. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995 Jun 01; 91(11):2742-7.
    View in: PubMed
    Score: 0.005
  23. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine. Biochem Pharmacol. 1995 Mar 30; 49(7):921-7.
    View in: PubMed
    Score: 0.005
  24. The faculty costs to educate a biomedical sciences graduate student. CBE Life Sci Educ. 2015 Mar 02; 14(1):ar3.
    View in: PubMed
    Score: 0.005
  25. Androgen regulation of thromboxane A2 receptors. Adv Prostaglandin Thromboxane Leukot Res. 1995; 23:251-3.
    View in: PubMed
    Score: 0.005
  26. Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancer. PLoS One. 2014; 9(9):e107530.
    View in: PubMed
    Score: 0.005
  27. Characterization of human peripheral blood monocyte thromboxane A2 receptors. J Pharmacol Exp Ther. 1994 Aug; 270(2):446-52.
    View in: PubMed
    Score: 0.004
  28. Endothelial progenitor cells and a stromal cell-derived factor-1a analogue synergistically improve survival in sepsis. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1509-19.
    View in: PubMed
    Score: 0.004
  29. Peroxiredoxin VI oxidation in cerebrospinal fluid correlates with traumatic brain injury outcome. Free Radic Biol Med. 2014 Jul; 72:210-21.
    View in: PubMed
    Score: 0.004
  30. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Biochim Biophys Acta. 1994 Mar 10; 1221(1):83-8.
    View in: PubMed
    Score: 0.004
  31. The Gordon Wilson Lecture. Regulation of thromboxane A2 receptors by testosterone: implications for steroid abuse and cardiovascular disease. Trans Am Clin Climatol Assoc. 1994; 105:95-103.
    View in: PubMed
    Score: 0.004
  32. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol. 1993 Dec; 265(6 Pt 1):E928-34.
    View in: PubMed
    Score: 0.004
  33. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension. Thromb Res. 1993 May 01; 70(3):205-10.
    View in: PubMed
    Score: 0.004
  34. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Aug; 262(2):632-7.
    View in: PubMed
    Score: 0.004
  35. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Jul; 262(1):238-45.
    View in: PubMed
    Score: 0.004
  36. Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. Mol Immunol. 2011 Oct; 49(1-2):64-74.
    View in: PubMed
    Score: 0.004
  37. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets. J Biol Chem. 1991 Jul 25; 266(21):13752-8.
    View in: PubMed
    Score: 0.004
  38. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. Biochem Pharmacol. 1991 Jul 15; 42(3):537-44.
    View in: PubMed
    Score: 0.004
  39. Novel synthesis and biochemical properties of an [125I]-labeled photoaffinity probe for thromboxane A2/prostaglandin H2 receptors. J Med Chem. 1991 Apr; 34(4):1511-4.
    View in: PubMed
    Score: 0.004
  40. Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor. Eur J Pharmacol. 1991 Jan 25; 206(1):15-21.
    View in: PubMed
    Score: 0.004
  41. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors. Biochem Pharmacol. 1990 Oct 01; 40(7):1457-61.
    View in: PubMed
    Score: 0.003
  42. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction. Circulation. 1990 Jan; 81(1):212-8.
    View in: PubMed
    Score: 0.003
  43. Characterization of thromboxane A2/prostaglandin H2 receptors in human vascular smooth muscle cells. Life Sci. 1990; 46(24):1765-72.
    View in: PubMed
    Score: 0.003
  44. I-BOP, the most potent radiolabelled agonist for the TXA2/PGH2 receptor. Adv Prostaglandin Thromboxane Leukot Res. 1990; 20:102-9.
    View in: PubMed
    Score: 0.003
  45. Radioligand binding assays for thromboxane A2/prostaglandin H2 receptors. Methods Enzymol. 1990; 187:397-405.
    View in: PubMed
    Score: 0.003
  46. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther. 1989 Nov; 251(2):557-62.
    View in: PubMed
    Score: 0.003
  47. Human platelets modulate edema formation in isolated rabbit lungs. J Clin Invest. 1989 Sep; 84(3):757-64.
    View in: PubMed
    Score: 0.003
  48. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1989 Sep; 250(3):923-7.
    View in: PubMed
    Score: 0.003
  49. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor. Biochim Biophys Acta. 1989 Jul 11; 1012(2):184-90.
    View in: PubMed
    Score: 0.003
  50. The role of eicosanoids in mediating blood flow alterations in endotoxin shock. Prog Clin Biol Res. 1989; 299:33-42.
    View in: PubMed
    Score: 0.003
  51. Photoaffinity labelling and isoelectric focusing of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor. Adv Prostaglandin Thromboxane Leukot Res. 1989; 19:168-71.
    View in: PubMed
    Score: 0.003
  52. Thromboxane and prostacyclin receptors. Prog Clin Biol Res. 1989; 301:21-8.
    View in: PubMed
    Score: 0.003
  53. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor. Prog Clin Biol Res. 1989; 301:303-7.
    View in: PubMed
    Score: 0.003
  54. Pharmacology of thromboxane A2 receptor antagonists. Z Kardiol. 1989; 78 Suppl 3:42-7.
    View in: PubMed
    Score: 0.003
  55. Thromboxane, prostaglandin and leukotriene receptors. Annu Rev Pharmacol Toxicol. 1989; 29:213-39.
    View in: PubMed
    Score: 0.003
  56. The rat in sepsis and endotoxic shock. Prog Clin Biol Res. 1989; 299:243-52.
    View in: PubMed
    Score: 0.003
  57. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. Biochem Biophys Res Commun. 1988 Dec 15; 157(2):733-9.
    View in: PubMed
    Score: 0.003
  58. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619. J Pharmacol Exp Ther. 1988 Dec; 247(3):1133-8.
    View in: PubMed
    Score: 0.003
  59. Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis. Cancer Res. 2008 Jun 01; 68(11):4097-104.
    View in: PubMed
    Score: 0.003
  60. Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels. Eur J Pharmacol. 1988 Apr 13; 148(3):309-15.
    View in: PubMed
    Score: 0.003
  61. Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets. Biochem Pharmacol. 1988 Feb 15; 37(4):647-54.
    View in: PubMed
    Score: 0.003
  62. Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents. Oncogene. 2008 Jan 03; 27(1):55-62.
    View in: PubMed
    Score: 0.003
  63. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant. Biochem Pharmacol. 1987 Jun 15; 36(12):1913-7.
    View in: PubMed
    Score: 0.003
  64. Cultured human vascular smooth muscle cells with functional thromboxane A2 receptors: measurement of U46619-induced 45calcium efflux. Circ Res. 1987 Jun; 60(6):952-6.
    View in: PubMed
    Score: 0.003
  65. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets. Prostaglandins. 1987 Jun; 33(6):789-97.
    View in: PubMed
    Score: 0.003
  66. Binding of thromboxane A2/prostaglandin H2 agonists to human platelets. Br J Pharmacol. 1987 May; 91(1):223-7.
    View in: PubMed
    Score: 0.003
  67. Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol Immunol. 2007 May; 44(12):3092-9.
    View in: PubMed
    Score: 0.003
  68. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors. Fed Proc. 1987 Jan; 46(1):149-53.
    View in: PubMed
    Score: 0.003
  69. Thromboxane A2 in health and disease. Fed Proc. 1987 Jan; 46(1):131-2.
    View in: PubMed
    Score: 0.003
  70. Photoaffinity labelling of a thromboxane A2/prostaglandin H2 antagonist binding site in human platelets. Biochem Biophys Res Commun. 1986 Oct 15; 140(1):128-33.
    View in: PubMed
    Score: 0.003
  71. Gi proteins regulate lipopolysaccharide and Staphylococcus aureus induced cytokine production but not (1--> 3)-beta-D-glucan induced cytokine suppression. Front Biosci. 2006 Sep 01; 11:2264-74.
    View in: PubMed
    Score: 0.003
  72. Human internal mammary artery produces more prostacyclin than saphenous vein. J Thorac Cardiovasc Surg. 1986 Jul; 92(1):88-91.
    View in: PubMed
    Score: 0.003
  73. Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes. J Biol Chem. 1986 Mar 05; 261(7):3025-9.
    View in: PubMed
    Score: 0.003
  74. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Intensive Care Med. 1986; 12(3):116-26.
    View in: PubMed
    Score: 0.002
  75. Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res. 2005 Dec 15; 65(24):11581-7.
    View in: PubMed
    Score: 0.002
  76. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Circulation. 1985 Dec; 72(6):1202-7.
    View in: PubMed
    Score: 0.002
  77. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. J Pharmacol Exp Ther. 1985 Dec; 235(3):729-34.
    View in: PubMed
    Score: 0.002
  78. Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism. 1985 Dec; 34(12 Suppl 1):32-6.
    View in: PubMed
    Score: 0.002
  79. Hydrodynamic properties of a thromboxane A2/prostaglandin H2 antagonist binding site solubilized from human platelets. Biochem Biophys Res Commun. 1985 Nov 15; 132(3):961-8.
    View in: PubMed
    Score: 0.002
  80. Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets. Proc Natl Acad Sci U S A. 1985 Nov; 82(21):7434-8.
    View in: PubMed
    Score: 0.002
  81. Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular disease. Ration Drug Ther. 1985 Jul; 19(7):1-7.
    View in: PubMed
    Score: 0.002
  82. Elevated plasma 6-keto-prostaglandin F1 alpha in patients in septic shock. Crit Care Med. 1985 Jun; 13(6):451-3.
    View in: PubMed
    Score: 0.002
  83. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther. 1985 May; 233(2):418-24.
    View in: PubMed
    Score: 0.002
  84. Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins. Eur J Pharmacol. 1985 Apr 23; 111(1):125-8.
    View in: PubMed
    Score: 0.002
  85. Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation. Shock. 2004 Jul; 22(1):57-62.
    View in: PubMed
    Score: 0.002
  86. Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-gamma. Shock. 2004 Mar; 21(3):254-60.
    View in: PubMed
    Score: 0.002
  87. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80.
    View in: PubMed
    Score: 0.002
  88. Hydrogen bond interactions of a series of N-substituted TXA2 receptor antagonists. Eur J Med Chem. 2003 Nov-Dec; 38(11-12):1015-24.
    View in: PubMed
    Score: 0.002
  89. The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cells. J Pharmacol Exp Ther. 2003 Dec; 307(3):1142-7.
    View in: PubMed
    Score: 0.002
  90. Involvement of G(i) proteins and Src tyrosine kinase in TNFalpha production induced by lipopolysaccharide, group B Streptococci and Staphylococcus aureus. Cytokine. 2003 Jun 07; 22(5):126-33.
    View in: PubMed
    Score: 0.002
  91. Do platelets have anything to do with diabetic microvascular disease? Diabetes. 1983 May; 32 Suppl 2:14-9.
    View in: PubMed
    Score: 0.002
  92. Thromboxane and prostacyclin in disease: a review. Q J Med. 1983; 52(208):461-70.
    View in: PubMed
    Score: 0.002
  93. Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294. Pulm Pharmacol Ther. 2003; 16(2):97-104.
    View in: PubMed
    Score: 0.002
  94. Platelets, prostaglandins, and coagulation in diabetes mellitus. Mt Sinai J Med. 1982 May-Jun; 49(3):215-22.
    View in: PubMed
    Score: 0.002
  95. Implication of Galpha i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production. J Endotoxin Res. 2002; 8(6):427-35.
    View in: PubMed
    Score: 0.002
  96. Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation. Thromb Res. 1981 Nov 15; 24(4):307-17.
    View in: PubMed
    Score: 0.002
  97. Signal transduction events in Chinese hamster ovary cells expressing human CD14; effect of endotoxin desensitization. Shock. 2001 Apr; 15(4):291-6.
    View in: PubMed
    Score: 0.002
  98. Increased platelet arachidonic acid metabolism in diabetes mellitus. Diabetes. 1981; 30(Suppl 2):44-8.
    View in: PubMed
    Score: 0.002
  99. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care. 1981 Jan-Feb; 4(1):121-33.
    View in: PubMed
    Score: 0.002
  100. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus. Horm Metab Res Suppl. 1981; 11:7-11.
    View in: PubMed
    Score: 0.002
  101. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med. 1981 Jan; 97(1):87-96.
    View in: PubMed
    Score: 0.002
  102. Suppression of Cox-2 and TNF-alpha mRNA in endotoxin tolerance: effect of cycloheximide, antinomycin D, and okadaic acid. Shock. 2000 Aug; 14(2):128-33.
    View in: PubMed
    Score: 0.002
  103. Platelet function in diabetes mellitus. Br J Haematol. 1980 Apr; 44(4):521-6.
    View in: PubMed
    Score: 0.002
  104. Urinary excretion of prostaglandin E like material and kallikrein: effects of furosemide. Prostaglandins. 1979 Sep; 18(3):359-68.
    View in: PubMed
    Score: 0.002
  105. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Proc Natl Acad Sci U S A. 1979 Aug; 76(8):4097-101.
    View in: PubMed
    Score: 0.002
  106. The effects of alpha adrenergic agents on human platelet aggregation. J Pharmacol Exp Ther. 1979 Mar; 208(3):366-70.
    View in: PubMed
    Score: 0.002
  107. Prostaglandins, thromboxanes, and platelet function. Curr Top Hematol. 1979; 2:75-143.
    View in: PubMed
    Score: 0.002
  108. Suppressed thromboxane production in endotoxin-desensitized THP-1 cells is not a result of decreased prostaglandin H synthase activity. Shock. 1998 May; 9(5):359-63.
    View in: PubMed
    Score: 0.001
  109. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1998 Apr 28; 95(9):4888-93.
    View in: PubMed
    Score: 0.001
  110. Endotoxin tolerance alters macrophage membrane regulatory G proteins. Prog Clin Biol Res. 1998; 397:217-26.
    View in: PubMed
    Score: 0.001
  111. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. N Engl J Med. 1977 Dec 15; 297(24):1306-10.
    View in: PubMed
    Score: 0.001
  112. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann Intern Med. 1977 Sep; 87(3):281-6.
    View in: PubMed
    Score: 0.001
  113. Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. Shock. 1996 Jan; 5(1):41-6.
    View in: PubMed
    Score: 0.001
  114. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther. 1994 Sep; 270(3):1192-6.
    View in: PubMed
    Score: 0.001
  115. Prostaglandins, thromboxanes, leukotrienes, and cytochrome P-450 metabolites of arachidonic acid. New Horiz. 1993 Feb; 1(1):60-9.
    View in: PubMed
    Score: 0.001
  116. Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis. 1991 Nov; 144(5):1095-101.
    View in: PubMed
    Score: 0.001
  117. Alcohol addiction and tetrahydropapaveroline. Science. 1970 Sep 11; 169(3950):1104-5.
    View in: PubMed
    Score: 0.001
  118. Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels. Proc Natl Acad Sci U S A. 1989 Jul; 86(14):5600-4.
    View in: PubMed
    Score: 0.001
  119. Alterations in Gc levels and complexing in septic shock. Circ Shock. 1989 Jul; 28(3):249-55.
    View in: PubMed
    Score: 0.001
  120. Treatment of pulmonary vasospasm with prazosin after atrial septal defect closure in a child. J Thorac Cardiovasc Surg. 1989 May; 97(5):802-4.
    View in: PubMed
    Score: 0.001
  121. Human platelets attenuate oxidant injury in isolated rabbit lungs. J Appl Physiol (1985). 1988 Sep; 65(3):1258-66.
    View in: PubMed
    Score: 0.001
  122. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes. Eicosanoids. 1988; 1(1):41-4.
    View in: PubMed
    Score: 0.001
  123. Extraction of thromboxane B2 from urine using an immobilized antibody column for subsequent analysis by gas chromatography-mass spectrometry. Prostaglandins. 1987 Feb; 33(2):149-60.
    View in: PubMed
    Score: 0.001
  124. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33.
    View in: PubMed
    Score: 0.001
  125. A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand. Biochem Pharmacol. 1985 Apr 15; 34(8):1165-70.
    View in: PubMed
    Score: 0.001
  126. Dazoxiben in human sepsis and adult respiratory distress syndrome. Clin Pharmacol Ther. 1985 Apr; 37(4):391-5.
    View in: PubMed
    Score: 0.001
  127. Lack of effect of glucocorticoids upon plasma thromboxane in patients in a state of shock. Surg Gynecol Obstet. 1985 Apr; 160(4):320-2.
    View in: PubMed
    Score: 0.001
  128. Studies of the kallikrein-kinin system and prostaglandins in epithelial ion transport. Soc Gen Physiol Ser. 1985; 39:121-33.
    View in: PubMed
    Score: 0.001
  129. Childhood familial and racial differences in physiologic and biochemical factors related to hypertension. Hypertension. 1983 Jan-Feb; 5(1):56-70.
    View in: PubMed
    Score: 0.001
  130. Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet. 1982 Jul 24; 2(8291):174-5.
    View in: PubMed
    Score: 0.000
  131. Cardiovascular effects of a 4'-methylthio analog of propranolol. J Pharmacol Exp Ther. 1981 Dec; 219(3):685-90.
    View in: PubMed
    Score: 0.000
  132. Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest. 1980 Feb; 65(2):543-54.
    View in: PubMed
    Score: 0.000
  133. Platelet adhesion and aggregation in diabetes mellitus. Metabolism. 1979 Apr; 28(4 Suppl 1):394-400.
    View in: PubMed
    Score: 0.000
  134. Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Intern Med. 1979 Feb; 139(2):225-30.
    View in: PubMed
    Score: 0.000
  135. Elevated prostaglandin production in cultured cells from a patient with fibrodysplasia ossificans progressiva. Prostaglandins. 1978 Jan; 15(1):123-9.
    View in: PubMed
    Score: 0.000
  136. Acetaminophen overdosage. J S C Med Assoc. 1977 Nov; 73(11):474-80.
    View in: PubMed
    Score: 0.000
  137. Studies on alkaline phosphatase activity cultured cells from a patient with fibrodysplasia ossificans progressiva. Lab Invest. 1977 Sep; 37(3):254-9.
    View in: PubMed
    Score: 0.000
  138. Histochemical and ultrastructural studies in fibrodysplasia ossificans progressiva (myositis ossificans progressiva). Am J Pathol. 1977 Jun; 87(3):483-98.
    View in: PubMed
    Score: 0.000
  139. Altered platelet function in diabetes mellitus. Diabetes. 1976; 25(2 SUPPL):826-31.
    View in: PubMed
    Score: 0.000
  140. Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. N Engl J Med. 1974 Jun 11; 291(2):83-5.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.